New drug safety trial launches in healthy adults
Knowledge-focused
Ongoing
This early-stage study is testing the safety and tolerability of a drug called midomafetamine in 32 healthy adults aged 18 to 55. Participants receive either a standard or a higher dose and are closely monitored for side effects, heart changes, and how the drug moves through the …
Phase: PHASE1 • Sponsor: Resilient Pharmaceuticals • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC